Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects

Published:2019-07 Issue:7 Volume:22 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Mofenson Lynne M¹^ORCID,Pozniak Anton L²^ORCID,Wambui Jacque³,Raizes Elliot⁴,Ciaranello Andrea⁵^ORCID,Clayden Polly⁶,Ehrenkranz Peter⁷^ORCID,Fakoya Ade⁸,Hill Andrew⁹^ORCID,Khoo Saye⁹^ORCID,Mahaka Imelda¹⁰,Modi Surbhi⁴^ORCID,Moore Cynthia⁴,Phillips Andrew¹¹^ORCID,Siberry George¹²,Sikwese Kenly¹³,Thorne Claire¹⁴^ORCID,Watts Heather D¹⁵,Doherty Meg¹⁶,Ford Nathan P¹⁶^ORCID

Affiliation:

1. Elizabeth Glaser Pediatric AIDS Foundation Washington DC USA

2. Chelsea and Westminster Hospital NHS Foundation Trust London School of Hygiene and Tropical Medicine London UK

3. National Empowerment Network of people living with HIV/AIDS in Kenya (NEPHAK) Nairobi Kenya

4. Centers for Disease Control and Prevention Atlanta GA USA

5. Massachusetts General Hospital Boston MA USA

6. HIV i‐Base London UK

7. Bill & Melinda Gates Foundation Seattle WA USA

8. Global Fund Geneva Switzerland

9. University of Liverpool Liverpool UK

10. Pangaea Zimbabwe AIDS Trust Harare Zimbabwe

11. University College London London UK

12. US Agency for International Development Arlington VA USA

13. African Community Advisory Board (AFROCAB) Luska Zambia

14. University College London Institute of Child Health London UK

15. Office of the US Global AIDS Coordinator Washington DC USA

16. World Health Organization Geneva Switzerland

Funder

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25352

Reference28 articles.

1. Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy

2. Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

3. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries

4. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “No One Needs to be Forced”: Qualitative Insights on Competing Priorities between Antiretroviral Therapy and Reproductive Health Planning during the Dolutegravir Rollout;AIDS and Behavior;2024-07-31

2. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis;BMC Pregnancy and Childbirth;2023-01-30

3. Contraception use and HIV outcomes among women initiating dolutegravir‐containing antiretroviral therapy in Kenya: a retrospective cohort study;Journal of the International AIDS Society;2022-12

4. Effectiveness of a structured stimulated spontaneous safety monitoring of medicines reporting program in strengthening pharmacovigilance system in Tanzania;Scientific Reports;2022-09-27

5. Adverse perinatal outcomes associated with prenatal exposure to protease- inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis;2022-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3